Michael L. Ferrebee, M.D.

         In 2005, after appointing Michael Lee Ferrebee, M.D. to a special committee for hospitals and nursing homes in West Virginia, Governor Joe Manchin appointed Dr. Ferrebee to the Board of Medicine.  Dr. Ferrebee is a member of the Board’s Complaint Committee.

            Dr. Ferrebee graduated from Wheeling College in 1984 and from the West Virginia University School of Medicine four years later.  In 1992, he completed post graduate Internship and Residency training at the Akron General Medical Center in Internal Medicine and Pediatrics and completed fellowship training at LeBonheur Children’s Hospital at the University of Tennessee in Memphis in 1995 in pediatric critical care.  Dr. Ferrebee was an assistant professor in Pediatrics for the next three years at the West Virginia University School of Medicine and was named West Virginia University Department of Pediatrics Outstanding Teacher of the Year, for 1995 – 96.  In 1993, Dr. Ferrebee was Board certified in Pediatrics and recertified in 2001.  He remains Board eligible in Internal Medicine and Pediatric Critical Care.

            In addition to a number of responsibilities in the Pediatrics Department at West Virginia University, over the years Dr. Ferrebee has served and continues to serve on a variety of committees at Monongalia General Hospital, in Morgantown.

            Dr. Ferrebee has worked in emergency rooms at Fairmont General Hospital, Stonewall Jackson Memorial Hospital and for the last six years has been a full-time staff ER physician at Monongalia General Hospital.  Subsequent to special study at the National Wound Healing Center in Columbus, Ohio, Dr. Ferrebee has practiced as a wound care and hyperbaric medicine physician at the Wound Healing Center of Monongalia General Hospital and his specialty at Monongalia General Hospital is emergency medicine.

            Dr. Ferrebee has co-authored several abstracts and a chapter on Adult Respiratory Distress Syndrome in The 5 Minute Clinical Consult (Griffith H, Dambro M) Philadelphia:  Lea & Febiger, 1992 – 2002.  He also shares four patents, with research colleagues, related to lysophosphatidate and patents on molecular cloning of the human homolog of the LPA receptor clone #1 LPAP and on molecular cloning of the mouse homolog of the LPA receptor-clone MLPARI.